Journal articleIndian J Surg Oncol2011
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.
- Journal
- Indian J Surg Oncol
- Published
- 17 February 2011
- Citations
- 183
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Pancreatic cancer is an aggressive tumor with a dismal prognosis, biomarkers that can detect tumor in its early stages when it may be amenable to curative resection may improve prognosis. At present, serum CA 19-9 is the only validated tumor marker in widespread clinical use, but precise knowledge of its role in pancreatic cancer diagnosis, staging, determining resectability, response to chemotherapy and prognosis remains limited. … Excerpt only: this text is the publisher’s. Read it in full at the source.